Genotoxicity of streptozotocin
Alejandro D Bolzán1, Martha S Bianchi
1Laboratorio de Citogenética y Mutagénesis, Instituto Multidisciplinario de Biología Celular (IMBICE), C.C. 403, 1900, La Plata, Argentina. adbolzan@netverk.com.ar
Mutation Research
|December 5, 2002
Summary
Streptozotocin (STZ) is an antibiotic that causes DNA damage and cell death. This review details its genotoxicity, mutagenicity, and carcinogenicity, highlighting its impact on pancreatic beta cells.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacology
Background:
- Streptozotocin (STZ) is a nitrosourea derivative with antibiotic and antineoplastic properties.
- It is widely used to induce experimental diabetes by targeting pancreatic beta cells.
- STZ is a potent alkylating agent with known genotoxic effects.
Purpose of the Study:
- To review the current understanding of Streptozotocin's genotoxicity.
- To consolidate knowledge on STZ's DNA-damaging capabilities.
- To highlight the significance of STZ genotoxicity research.
Main Methods:
- Literature review of studies on Streptozotocin's biological effects.
- Analysis of data on STZ-induced DNA damage markers.
- Examination of mutagenicity and carcinogenicity assays.
Main Results:
- STZ induces various DNA lesions, including strand breaks and adducts.
- It causes chromosomal aberrations, micronuclei, and sister chromatid exchanges.
- STZ is mutagenic in bacterial and eukaryotic systems and carcinogenic in rodents.
Conclusions:
- Streptozotocin exhibits significant genotoxic, mutagenic, and carcinogenic properties.
- Free radical involvement is implicated in STZ-induced DNA damage.
- Understanding STZ's genotoxicity is crucial due to its clinical applications.
More Related Videos
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:16In-vitro Mutagenesis
15.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.9K
01:26Toxic Reactions: Overview
1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
542
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
542
01:33Cancer-Critical Genes I: Proto-oncogenes
11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K